David Teachey, MD, Pediatric Hematology & Oncology, Philadelphia, PA, Children's Hospital of Philadelphia

DavidTTeacheyMD

Pediatric Hematology & Oncology Philadelphia, PA

Associate Professor at Children's Hospital of Philadephia

Dr. Teachey is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Teachey's full profile

Already have an account?

  • Office

    34th & Civic Center Blvd
    Children's Hospital Of Philadelphia
    Philadelphia, PA 19104
    Phone(215) 590-1000
    Fax(215) 590-4183
  • Is this information wrong?

Education & Training

  • Children's Hosp PhiladelphiaFellowship, 2005
  • Children's National Medical Center - George Washington University
    Children's National Medical Center - George Washington UniversityResidency, Pediatrics, 2002
  • Eastern Virginia Medical School
    Eastern Virginia Medical SchoolClass of 1999

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2020 - Present
  • PA State Medical License
    PA State Medical License 2002 - 2022
  • DC State Medical License
    DC State Medical License 2001 - 2004
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Targeting EIF4E Signaling with Ribavirin in Infant Acute Lymphoblastic Leukemia  
    Nyla A Heerema, James W Davenport, Carolyn A Felix, Andrew J Carroll, ZoAnn E Dreyer, Alix E Seif, David T Teachey, Joanne M Hilden, Sarah K Tasian, Cheryl L Willman, ..., Nature

Press Mentions

  • Game-Changing Coronavirus Treatment Might’ve Just Saved a Child’s Life
    Game-Changing Coronavirus Treatment Might’ve Just Saved a Child’s LifeApril 22nd, 2020
  • 'Potentially Promising': Doctors in Philadelphia Treat Pediatric COVID-19 Patient with Plasma
    'Potentially Promising': Doctors in Philadelphia Treat Pediatric COVID-19 Patient with PlasmaApril 22nd, 2020
  • Study: Sirolimus Is Effective, Safe for Treatment-Resistant Autoimmune Blood Conditions
    Study: Sirolimus Is Effective, Safe for Treatment-Resistant Autoimmune Blood ConditionsOctober 26th, 2015
  • Join now to see all

Grant Support

  • Targeting The Mtor Signaling Pathway In Autoimmune Lymphoproliferative SyndromeNational Institute Of Allergy And Infectious Diseases2011

Hospital Affiliations